Skip to content

Pulpotomy in Mature Permanent Molars Using Biodentine Versus MTA

Comparative Evaluation of Postoperative Pain and Success Rate After Pulpotomy in Mature Permanent Molars Using Biodentine Versus Mineral Trioxide Aggregate (MTA) as Capping Materials: A Randomized Clinical Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03890835
Enrollment
70
Registered
2019-03-26
Start date
2019-05-31
Completion date
2020-05-31
Last updated
2019-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Symptomatic Irreversible Pulpitis

Keywords

Pulpotomy, Mineral Trioxide Aggregate (MTA), Biodentine, Vital pulp therapy, Postoperative pain, Overall success

Brief summary

The aim of this study is to compare treatment outcomes of pulpotomy in mature permanent teeth using Biodentine versus MTA regarding postoperative pain and success rate.

Detailed description

* Patients will be clinically and radiographically examined and their eligibility will be assessed. * Eligible patients will be randomly assigned to one of 2 groups: experimental group (pulpotomy using Biodentine) and the control group (pulpotomy using MTA). * After adminsrtation of local anesthesia, pulpotomy will be done under rubber dam isolation. The pulp tissue will be removed until the level of the orifices of the canals. After hemostasis is achieved, the capping material will be placed. In the experimental group, the capping material is Biodentine while in the control group, the capping material is MTA * The cavities will be sealed with resin-modified glass ionomer. Then the teeth will be permanently restored with composite . A post-operative radiograph will be taken. * The patients will be given a pain diary based on Numerical Rating Scale (NRS) and asked to rate their pain level at the specified times. * The patients will be recalled after 6 and 12 months post-operatively.

Interventions

PROCEDUREMTA Pulpotomy.

Pulpotomy using MTA.

Pulpotomy using Biodentine

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

The study will be participant-blind where the participant will not know the intervention done.

Intervention model description

Type: Two arm, parallel, randomized clinical trial. Allocation ratio: 1:1 Framework: Superiority.

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Patients aging between 18-40 years old * Patients with symptomatic irreversible pulpitis. * Radiographically: Absence or slight widening in periodontal ligament space. * Systemically- healthy patients (ASA I or II). * Patients who agree to attend for recall appointments and provide written consent.

Exclusion criteria

* Severe marginal periodontitis. * Necrotic pulp, pulp polyp, tooth tender to percussion, clinical progression into periapical abscess, fistula. * Non-restorable teeth, teeth with internal/external root resorption or root canal calcification.

Design outcomes

Primary

MeasureTime frameDescription
Postoperative pain after 6 hours postoperatively6 hours postoperativelyEach patient will be given a pain diary based on Numerical Rating Scale(NRS). NRS is an 11-point scale consisting of numbers from 0 through 10. 0 reading represents no pain 1- 3 readings represent mild pain 4- 6 readings represent moderate pain 7- 10 readings represent severe pain
Postoperative pain after 12 hours postoperatively12 hours postoperativelyEach patient will be given a pain diary based on Numerical Rating Scale(NRS). NRS is an 11-point scale consisting of numbers from 0 through 10. 0 reading represents no pain 1- 3 readings represent mild pain 4- 6 readings represent moderate pain 7- 10 readings represent severe pain
Postoperative pain after 24 hours postoperatively24 hours postoperativelyEach patient will be given a pain diary based on Numerical Rating Scale(NRS). NRS is an 11-point scale consisting of numbers from 0 through 10. 0 reading represents no pain 1- 3 readings represent mild pain 4- 6 readings represent moderate pain 7- 10 readings represent severe pain

Secondary

MeasureTime frameDescription
Overall (clinical and radiographic) success after 6 months postoperatively.6 months postoperativelyOutcome of overall success will be determined based on clinical and radiographic examination. If there is either clinical or radiographic failure , then the case will be considered as an overall failure.
Overall (clinical and radiographic) success after 12 months postoperatively.12 months postoperativelyOutcome of overall success will be determined based on clinical and radiographic examination. If there is either clinical or radiographic failure , then the case will be considered as an overall failure.

Contacts

Primary ContactYoussef A. Kamal Elalfy, B.D.S
Youssef_Andraws@dentistry.cu.edu.eg+201286069484
Backup ContactSuzan AW Amin, Ph.D.
swaness@rocketmail.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026